홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

HCID 10612278, 화합물 → HCID 58487999, 화합물

HRID 1677747
인쇄

반응식

HRID 1677747 반응식
[CH3:1][C@H:2]1[NH:7][CH2:6][CH2:5][N:4](C2C=CC(CCC)=CC=2)[CH2:3]1.Br[C:18]1[CH:23]=[CH:22][C:21]([C:24]2[C:28]3[CH:29]=[CH:30][CH:31]=[CH:32][C:27]=3[O:26][CH:25]=2)=[CH:20][CH:19]=1>>[O:26]1[C:27]2[CH:32]=[CH:31][CH:30]=[CH:29][C:28]=2[C:24]([C:21]2[CH:22]=[CH:23][C:18]([N:4]3[CH2:5][CH2:6][NH:7][C@H:2]([CH3:1])[CH2:3]3)=[CH:19][CH:20]=2)=[CH:25]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 10612278HCID 10612278, 화합물HCID 58487948(3R)-3-methyl-1-(4-propylphenyl)piperazine

생성물 1

HCID 58487999HCID 58487999, 화합물수율 21%

실험 절차

The title compound was prepared following the procedure of Intermediate 17, but starting from 3-(4-bromophenyl)-1-benzofuran (obtained as described in Malamas et al., 2000, J. Med. Chem., 43, 1293-1310). Purification by chromatography (DCM/MeOH 80/20) afforded the title compound as beige solid (21%). HPLC (Condition A), Rt: 3.0 min (HPLC purity: 93.4%). M+(ESI): 293.2

후처리

  1. customThe title compound was prepared
  2. customPurification by chromatography (DCM/MeOH 80/20)

출처 및 근거

ORD 기록
ord-4d342ac87e074cb2ae15a554d808de05
출처 데이터셋
uspto-grants-2011_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08008302B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트